In young adult DCM patients post-HTx, heightenedbaseline levels of NT-proBNP and UA levels and a sustained reduction in LVEF overtime prior to undergoing an HTx are significantly associated with an increasedrisk of adverse events post-HTx. This evidence concerns the gene NPPB and familial dilated cardiomyopathy.